Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06068985
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2023-09-19
Brief Title:
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2 Early Breast Cancer Undergoing HER2 Double-Blockade
Sponsor:
Latin American Cooperative Oncology Group
Organization:
Latin American Cooperative Oncology Group
Organization Data
Organization:
Latin American Cooperative Oncology Group
Class:
OTHER
Study ID:
LACOG 0721
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Latin American Cooperative Oncology Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Oncoclínicas | INDUSTRY |
| Roche Pharma AG | INDUSTRY |